CD93 and cancer: We found that C3AR1 expression is higher in GBM as compared with all other cancers analyzed in TCGA (Figure 4A), whereas Complement Receptor 1 (CR1), CR2, C1qR1 (CD93), and C5AR1 were expressed at varying levels (Supplemental Figure 4, A–D).